Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung Cancer
- Conditions
- Non Small Cell Lung CancerResistance Exercise
- Interventions
- Behavioral: Resistance Exercise
- Registration Number
- NCT05014035
- Lead Sponsor
- University of South Carolina
- Brief Summary
Symptom burden remains a critical concern for individuals with non-small cell lung cancer (NSCLC) following the completion of treatment. Of those, symptom clusters such as dyspnea (shortness of breath) and fatigue, contribute to physical decline, reductions in quality of life, and a higher risk of comorbidities and mortality. It has been proposed that dyspnea is a primary limiter of exercise capacity in individuals with lung cancer, resulting in exercise avoidance and an accelerated physical decline. As such, specifically designing resistance exercise programs with cluster sets, to mitigate feelings of dyspnea and fatigue may result in improved exercise tolerance, resulting in the maintenance of physical function and quality of life.
The purpose of this project is to investigate the feasibility and preliminary efficacy of a hybrid-delivery of home-based cluster-set resistance exercise in individuals with NSCLC. Methods: Individuals with NSCLC (n=15), within 12-months of completion of treatment will be recruited to participate in this single arm feasibility trial. Participants will complete 8-weeks of home-based resistance training (RT) designed to target dyspnea and fatigue. The hybrid-delivery of the program will include supervised sessions in the participants home, and virtual supervision via video conferencing. The primary outcome of feasibility will be measured via recruitment rates, retention, acceptability and intervention fidelity. Exploratory outcomes (dyspnea, fatigue, quality of life, physical function and body composition) will be assessed pre- and post- intervention.
- Detailed Description
Analysis plan. Descriptive statistics (percentages and means (with standard deviations)) will be used to report on feasibility outcomes (recruitment, retention, fidelity etc.). Unless explicitly stated, means and standard deviations will be reported for assessments of exploratory outcomes at baseline and follow-up.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 14
- Completed definitive treatment for localized NSCLC (stages I-III)
- Has access to stable internet access for Zoom participation
- Willing to complete an 8-week, home-based intervention program that includes face-to-face and Zoom interaction.
- Willing to consider behavior change at this time.
- Able to speak and read English.
- Capable of informed consent
- Has obtained medical clearance from medical practitioner or medical team
- Individuals with a known diagnosis of advanced lung cancer (stage IV; due to potential added burden) or diagnosis of small-cell lung cancer,
- Anyone for whom physical activity is not recommended.
- aren't comfortable having study staff visit their homes for exercise sessions
- have any neuromuscular, cardiovascular, or psychological condition precluding safe exercise;
- have participated in structured RE ≥2 times/week for the past 6 months;
- are unable to read/understand English.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Exercise Intervention Resistance Exercise -
- Primary Outcome Measures
Name Time Method Intervention Fidelity Through study completion, an average of 1 year Exercise fidelity will be reported using metrics previously outlines by Fairman et al (2019). Specifically, volume load will be calculated as a function of sets x reps for each exercise and summed to give total volume for each session. We will report the proportion of volume achieved relevant to what was prescribed to give a "relative-dose intensity" (RDI) for each person. RDI will then be averaged and used to determine fidelity to the RT intervention.
Recruitment Through study completion, an average of 1 year The recruitment goal of n=15 is reached
Retention Through study completion, an average of 1 year If ≥75% of the sample recruited to participate return for follow up testing
- Secondary Outcome Measures
Name Time Method Physical Function STS Baseline and post intervention (8-weeks) 5 times sit-to-stand (in seconds)
Lower Body Muscular Strength Baseline and post intervention (8-weeks) Leg Press five repetition maximum
Fat Mass Baseline and post intervention (8-weeks) Fat mass (kg) Dual Energy X-Ray Absorptiometry
Fat Free Mass Baseline and post intervention (8-weeks) Fat Free Mass (kg) Dual Energy X-Ray Absorptiometry
Bone Mineral Density Baseline and post intervention (8-weeks) Total z-score Dual X-ray Absorptiometry
Dyspnea Baseline and post intervention (8-weeks) Functional Assessment of Chronic Illness Therapy-Dyspnea (FACIT-D) 10-Item short form (parts 1 and 2). Part 1 assesses Dyspnea and Part 2 assesses dyspnea-associated functional limitations. Min score for each part: 0; max score for each part: 30. Higher scores indicate worse dyspnea/burden
Body Fat Percentage Baseline and post intervention (8-weeks) Dual Energy X-Ray Absorptiometry
Acceptability Post-Intervention (8-weeks) Qualitative interview with participants regarding the acceptability, likes, dislikes about the intervention and potential barriers for future participation.
Fatigue Baseline and post intervention (8-weeks) Functional Assessment of Chronic Illness Therapy-Fatigue scale 13-item scale. Min score: 0 Max score: 52 Higher scores mean higher quality of life.
Total Mass Baseline and post intervention (8-weeks) Total Mass (kg) Dual Energy X-Ray Absorptiometry
Appendicular Lean Mass Baseline and post intervention (8-weeks) Sum of Arm and Leg Fat Free Mass
Physical Function 6MWT Baseline and post intervention (8-weeks) 6-minute Walk Test (distance in meters)
Lung Cancer Related Quality of Life Baseline and post intervention (8-weeks) Functional Assessment of Cancer Therapy - Lung Cancer Subscale (LCS). Min score: 0; max score: 28. Higher scores indicate better quality of life.
Upper Body Muscular Strength Baseline and post intervention (8-weeks) Chest Press five repetition maximum
Trial Locations
- Locations (1)
University of South Carolina
🇺🇸Columbia, South Carolina, United States